Abda Labs

What Abda Labs does

ABDA Labs is a privately held, CLIA-certified reference laboratory headquartered at 8006 Cameron Road, Suite A, Austin, Texas, operating under the laws of the State of Texas. The company provides molecular diagnostics, toxicology, and third-party peptide Certificate of Analysis (COA) testing services to independent clinical laboratories, physician offices, clinics, hospitals, urgent care providers, and RUO peptide manufacturers, with active partner recruitment in Central Texas and stated reach beyond the region. Its core technology stack is conventional clinical laboratory instrumentation: Real-Time PCR (qPCR) for multiplex pathogen detection and antibiotic resistance marker identification, LC-MS/MS for toxicology confirmation, and HPLC for peptide purity analysis, accessed through a HIPAA-compliant Provider Portal with optional HL7 v2 and FHIR integration for EMR/LIS connectivity.

The product portfolio consists of five PCR pathogen panels (Respiratory Pathogen Panel P031, Urinary Tract Infection Panel P029, Sexually Transmitted Infection Panel P002, Wound Infection Panel P030, and Nail Fungus Infection Panel P006), a comprehensive toxicology validity / screening / confirmation service, and a distinct RUO Peptide COA testing line. Reported turnaround times are 24–48 hours for molecular panels and up to 72 hours for toxicology, with prepaid FedEx overnight shipping included. The company publishes per-test pricing with no hidden fees, no setup fees, no monthly minimums, and no long-term contracts; the EMR/LIS integration is structured as a paid add-on.

ABDA Labs monetizes exclusively through per-test and per-sample transaction fees distributed across two onboarding tracks: a Clinical Provider / Reference Lab track and an RUO Peptide Manufacturer track. Go-to-market is sales-led with a self-serve onboarding portal, targeting primarily mid-market healthcare providers with a stated value proposition of faster turnaround, transparent pricing, no minimum volumes, and direct human support, positioning explicitly against large reference laboratories. The company is actively pursuing CAP accreditation to supplement its existing CLIA high-complexity certification. No funding rounds, management team, headcount, or financial figures are disclosed in the available data.

Name

Abda Labs

Legal name

ABDA Labs

Website

https://abdalabs.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

ABDA Labs is a CLIA-certified reference laboratory in Austin, Texas offering PCR-based molecular diagnostics, toxicology, and RUO peptide COA testing to independent clinical labs, physician offices, hospitals, and peptide manufacturers with 24–48 hour turnaround and no minimum volumes.

Ownership category

akta.pro rank

Product category

Reference Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro industry

PRIMARYHLAFAMAB

Clinical Chemistry & Immunoassay Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAGADAA

Bioanalytical Testing (PK/ADA/NAb)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLACAMAL

Lab Data Exchange & Interoperability (HL7/FHIR/LDT Results Delivery)

Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics

SECONDARYHLACAMAA

Clinical Laboratory LIS (Core Lab/Hospital Lab)

Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics

Keywords

• Molecular diagnostics testing
• Reference laboratory services
• Toxicology screening
• Peptide certificate analysis
• Clinical PCR panels

Headquarters

HQ city

San Diego

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Molecular Diagnostic Testing: Per-test fees for PCR-based pathogen detection panels including Respiratory Pathogen Panel (P031), Urinary Tract Infection Panel (P029), STI Panel (P002), Wound Infection Panel (P030), and Nail Fungus Panel (P006). Results delivered within 24-48 hours of specimen receipt.
2. Toxicology Testing: Per-test fees for comprehensive drug screening with specimen validity testing, immunoassay screening, and LC-MS/MS confirmation. Results delivered within 72 hours (5 days) of specimen receipt.
3. Peptide COA Testing: Per-sample fees for third-party peptide identity and purity testing for RUO peptide manufacturers. Standard turnaround is 5 business days from sample receipt, with expedited turnaround available.
4. EMR/LIS Integration Services: Optional paid add-on for qualified partners requiring direct LIS or EMR integration via HL7 v2 or FHIR protocols.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

ABDA Labs is a CLIA-certified reference laboratory that performs molecular diagnostic PCR pathogen panels (respiratory, UTI, STI, wound, nail fungus), comprehensive toxicology screening with LC-MS/MS confirmation, and third-party HPLC/LC-MS/MS Certificate of Analysis testing for research-use-only peptides. Services are delivered to independent labs, physician offices, urgent care clinics, hospitals, and peptide manufacturers with results returned in 24-72 hours through a HIPAA-compliant Provider Portal, with no minimum volume requirements.

Product overview

ABDA Labs is a CLIA-certified reference laboratory offering a portfolio of molecular diagnostics and toxicology testing services. The core offering consists of PCR-based pathogen detection panels (Respiratory Pathogen Panel, Urinary Tract Infection Panel, Sexually Transmitted Infection Panel, Wound Infection Panel, Nail Fungus Infection Panel) combined with a comprehensive Toxicology Validity, Screening & Confirmation service. A secondary service line provides third-party RUO Peptide COA Testing for peptide manufacturers. All clinical testing is accessed through a HIPAA-compliant Provider Portal, with results typically delivered within 24-48 hours for molecular tests and 72 hours for toxicology. No minimum volume requirements and transparent per-test pricing differentiate the offering from traditional reference labs.

Differentiator

Problem solved

Functional benefit

Products and services

• Respiratory Pathogen Panel

Quantifiable outcome

• Turnaround time reduced from 4-5 business days to 24-48 hours
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

One partnership is on record.

• College of American Pathologists (CAP)minorOthersABDA Labs is actively pursuing CAP accreditation, an internationally recognized standard for clinical laboratory quality. CAP accreditation will be posted here once issued.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Eurofins Scientific: Global laboratory testing services group with strong presence in clinical diagnostics, pharmaceutical, and food/feed testing. Relevant peer for ABDA Labs' LC-MS/MS-based peptide COA testing and broader clinical diagnostics service.
• Quest Diagnostics: National reference laboratory offering PCR molecular diagnostics, toxicology, and broad test menus to physicians and hospitals. Cited implicitly as the type of large reference lab ABDA Labs positions against on turnaround, pricing transparency, and minimum-volume flexibility.
• ARUP Laboratories: Hospital-based reference lab known for esoteric and specialty testing with strong quality credentials. Comparable as a reference lab serving external providers with clinical and specialty assays, though at much larger scale than ABDA Labs.
• Sonic Healthcare USA: Network of US clinical reference labs providing anatomic pathology, molecular diagnostics, and toxicology. Comparable as a multi-brand reference lab operator with overlapping test menu and customer base to ABDA Labs.
• Mayo Clinic Laboratories: Reference lab offering specialized clinical and esoteric testing to providers nationwide. Comparable as a clinical reference lab serving physician offices and hospitals with advanced molecular and chemistry testing, but operating at far greater scale and brand authority.
• Laboratory Corporation of America (Labcorp): National reference lab providing molecular diagnostics, toxicology, and a broad clinical test menu. ABDA Labs' value proposition (faster turnaround, no minimums, transparent per-test pricing, real customer support) is directly framed against the kind of service experience Labcorp and similar incumbents deliver.

Emerging players

• Viracor Eurofins: Specialty reference lab focused on infectious disease and immunology molecular diagnostics. Comparable as a specialty molecular diagnostics provider serving hospitals and reference lab clients with PCR-based pathogen panels similar to ABDA Labs' RPP, UTI, STI, and wound offerings.
• Precision Analytical / Access Labs: Smaller specialty reference lab offering molecular and toxicology testing to providers with emphasis on service quality and turnaround. Comparable as a smaller-scale clinical reference lab pursuing a similar service-quality differentiation strategy against national incumbents.

Direct peers

• PathGroup: Mid-sized physician-focused reference laboratory providing molecular diagnostics, toxicology, and anatomic pathology. Direct comparable to ABDA Labs in target customer (independent practices), service mix (PCR + toxicology), and emphasis on partner-friendly service.

Regional players

• Clinical Pathology Laboratories (CPL/Sonic Healthcare): Regional clinical reference laboratory based in the Southwest US, offering molecular, chemistry, and toxicology testing to physicians and clinics. Comparable regional peer whose Austin-area footprint directly overlaps ABDA Labs' Central Texas focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abda Labs